Provided by Tiger Trade Technology Pte. Ltd.

GoodRx Holdings, Inc.

3.46
-0.0300-0.86%
Post-market: 3.44-0.0200-0.58%18:35 EDT
Volume:1.59M
Turnover:5.56M
Market Cap:1.18B
PE:72.89
High:3.59
Open:3.46
Low:3.45
Close:3.49
52wk High:5.81
52wk Low:1.77
Shares:341.15M
Float Shares:93.97M
Volume Ratio:1.02
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0475
EPS(LYR):0.0854
ROE:2.52%
ROA:3.05%
PB:1.82
PE(LYR):40.50

Loading ...

Analyst Rating Updates: NVIDIA and Meta Upgraded, GoodRx Downgraded

Deep News
·
May 23

Amazon.com Pharmacy, GoodRx Discounts Integrated Into TrumpRx.gov

MT Newswires Live
·
May 19

GoodRx Holdings Is Maintained at Buy by Citigroup

Dow Jones
·
May 15

Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and DaVita (DVA)

TIPRANKS
·
May 11

Analyst Maintains Buy on GoodRx as High-Value Segments Gain Traction; Price Target Kept at $3.50

TIPRANKS
·
May 10

GoodRx Earnings Call Highlights Pharma Direct Momentum

TIPRANKS
·
May 09

GoodRx price target raised to $3.50 from $2.50 at Goldman Sachs

TIPRANKS
·
May 09

GoodRx Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Earnings Flash (GDRX) GoodRx Posts Q1 Revenue $194M, vs. FactSet Est of $185.4M

MT Newswires Live
·
May 07

BRIEF-GoodRx Holdings Q1 Adjusted Net Income USD 23 Million Vs. IBES Estimate USD 24.7 Million

Reuters
·
May 07

GoodRx Holdings Guidance 2026 Adjusted Ebitda >$235

THOMSON REUTERS
·
May 07

GoodRx Holdings Guidance 2026 Revenue $765 - $785 Millions

THOMSON REUTERS
·
May 07

GoodRx Holdings Inc expected to post earnings of 7 cents a share - Earnings Preview

Reuters
·
May 05

GoodRx files Form 3 for Chief Accounting Officer Thomas Chan

Reuters
·
May 02

GoodRx offers Ozempic pill for Type 2 diabetes

TIPRANKS
·
May 01

BRIEF-Goodrx Expands Offerings To Now Include Ozempic® Pill For Type 2 Diabetes Patients

Reuters
·
May 01

GoodRx Holdings Inc - Ozempic Pill Priced at $149 (1.5Mg), $199 (4Mg), $299 (9Mg) per Month

THOMSON REUTERS
·
May 01

GoodRx Expands Offerings to NOW Include Ozempic® Pill for Type 2 Diabetes Patients

THOMSON REUTERS
·
May 01

GoodRx publishes 2025 annual report

Reuters
·
May 01

GoodRx names Thomas Chan chief accounting officer

Reuters
·
Apr 25